Nanopharm https://validator.w3.org/feed/docs/rss2.html Rethinking bioequivalence for nasal suspensions: Adopting an in-vitropathway with confidence Aligning Alternative Bioequivilence with U.S. FDA: Advancing aerosol dose collection to enhance in vitro dissolution studies Automating pMDI Actuation for Consistent In Vitro Bioequivalence Testing Microstructural Characterization of Dry Powder Inhaler Formulations Using Orthogonal Analytical Techniques Targeting accelerated progress at the IPAC-RS Nasal Innovation Forum 2025 Content Download | Microstructural Characterization of Dry Powder Inhaler Formulations Using Orthogonal Analytical Techniques GDUFA: FDA adds further weight to modelling and simulation’s role in bioequivalence Locations Leadership Team Clinical Trial Manufacturing Analytical Section cGMP Release & Stability Testing cGMP Release & Stability Testing Regulatory Consultancy Spray Drying and Particle Engineering Clinical Labeling Accelerating OINDP Development with Nanopharm Optimizing OINDP Regulatory Paths With Model Master Files (MMF)  Content Download | Nanopharm: cGMP Drug Development in OINDP OINDP Expertise – Nasal Cast (Aeronose) Content Download | OPTIMIZING OINDP REGULATORY PATHS WITH MODEL MASTER FILES Nanopharm’s Nasal Spray for SARS-CoV-2 Antibody Treatment Content Download | Nanopharm’s Nasal Spray for SARS-CoV-2 Antibody Treatment Clinical Development Content Download | Accelerating OINDP Development with Nanopharm Nanopharm’s Innovations in Nasal Drug Delivery of Biologics Advanced microscopy techniques to assess solid-state properties of inhalation medicines Nanopharm: Valve Types & Container Systems in pMDIs with Salmeterol Nanopharm: cGMP Drug Development in OINDP Nasal Drug Development, Trends and Challenges with Nasal Formulations Nasal Drug Development, Trends and Challenges with Nasal Formulations SmartTrack Content Download | Nanopharm’s Innovations in Nasal Drug Delivery of Biologics News & Events Resources Nanopharm’s Role in OINDP Bioequivalence & Pharmacokinetics Content Download | Nanopharm’s Role in OINDP Bioequivalence & Pharmacokinetics Content Download | Nanopharm: cGMP Drug Development in OINDP About Us Nanopharm’s SmartTrack: Accelerating OINDP Respiratory Drug Delivery Content Download | Nanopharm’s SmartTrack: Accelerating OINDP Respiratory Drug Delivery Characterizing Nasal Suspensions for Regulatory and Scientific Purposes Content Download | Characterizing Nasal Suspensions for Regulatory and Scientific Purposes Home Effect of Device Design and Formulation on the In Vitro Comparability for Multi-Unit Dose Dry Powder Inhalers Content Download | Effect of Device Design and Formulation on the In Vitro Comparability for Multi-Unit Dose Dry Powder Inhalers Content Download | Advanced microscopy techniques to assess solid-state properties of inhalation medicines Aptar Pharma Bolsters Clinical Trial Capabilities with Strategic Materials Manufacturing Acquisition A respirable HPV-L2 dry-powder vaccine with GLA as amphiphilic lubricant and immune-adjuvant Content Download | A respirable HPV-L2 dry-powder vaccine with GLA as amphiphilic lubricant and immune-adjuvant Nanopharm Announces Exclusive Collaboration With Fluidda To Accelerate Regulatory Pathway For OINDP Using SmartTrack